| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-09 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-09 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-09 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-08 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-08 |